Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 756 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
14 Мб
Скачать
498
https://t.me/med1917
asymptomatic bacteriuria but to treat only if symptomatic [31]. Preoperative respi­ratory infections, such as pneumonia or COVID-19, have been identied as risk factors for increased postoperative mortality and complications such as prolonged ventilation or need for reintubation [3234]. It is recommended that surgery be delayed, if possible, until any respiratory infection is treated.
R. Parrish and R. Findley
Tobacco Use
Tobacco use is associated with increased risk of POCs including wound healing concerns, infection, pulmonary complications, and prolonged LOSH [3537]. Historic observations suggested there was increased sputum production and change in cough if smoking stopped within a few weeks of surgery. This has not been sub­stantiated and a meta-analysis demonstrated that there is no increased risk of POCs if smoking cessation occurs within 8weeks of an operation [35].
While increased complications with smoking cessation have not been shown, a reduction in POCs has also not been denitively shown if there is a short interval between cessation and surgery [37]. Behavioral support and nicotine replacement therapy may improve short-term smoking cessation complaints and should be offered to help minimize discomfort [38]. For motivated patients wishing long-term cessation, there is evidence of benet for intensive intervention started at least 4weeks prior to surgery. These patients may have fewer complications overall, with a potentially signicant reduction in wound complications [38].
Ethanol Use
Alcohol use is common among patients and national guidelines substantially vary on recommended daily maximum intake. High alcohol intake, or “risky drinking,” can be tentatively dened as more than three alcoholic units per day or 21 per week. Indeed, the World Health Organization states that no level of alcohol consumption is safe for health. One unit equals 12g of ethanol in Italy, Sweden, and some other parts of Europe, or one small glass of wine, with a worldwide range of 8–20g/unit [39]. While alcohol use can cause disorders of the liver, pancreas, and nervous sys­tem, it may also impact other physiologic systems that increase the risk for periop­erative complications. Alcohol intake greater than three units per day can compromise the immune response, increase the risk of cardiac insufciency and arrhythmias, and alter blood clotting time [39].
Available data suggests that short and long-term interventions can decrease alco­hol use in the perioperative period, but data are lacking on whether there is a cor­responding reduction in complication rates [39]. Preoperative alcohol screening is encouraged to prevent POCs from alcohol withdrawal syndrome, nominally delir- ium tremens which can impact LOSH as well as mortality [40].
29 Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery…
https://t.me/med1917
499
Nutritional Status
At least 30% of hospitalized patients undergoing major surgery are malnourished [41, 42]. Malnutrition is an independent predictor of POCs including increased LOSH in both the oncologic and non-oncologic patient group [41, 43, 44]. Large data available from the National Surgical Quality Improvement Program (NSQIP) identies malnutrition as a modiable risk factor for reducing postoperative mortal­ity and morbidity [42, 43]. The impacts of malnutrition are broad, including impaired immune function, changes in digestion and absorption, muscle weakness leading to respiratory complications, and wound healing troubles [45].
Dening malnutrition can be challenging. Measurement of serum albumin can be applied to preoperative patients; however, it can be impacted by stress, infection, and organ dysfunction separate from malnutrition [46]. Albumin levels lower than 3g/dL are associated with signicantly higher rates of POCs and 30-day mortality [43]. Other studies suggest that an even higher threshold for hypoalbuminemia should be considered, with a cutoff of 4g/dL [41]. Body mass index (BMI) may also be a surrogate marker for malnutrition as those with a BMI less than 18.5kg/
2
m
, or less than 20kg/m2 if older than 65, have higher rates of POCs [42]. A more formal assessment of nutrition status such as the Perioperative Nutrition Screen (PONS) integrates BMI, recent unintentional weight loss, dietary intake, and serum albumin, and vitamin D levels to provide a risk score. It is recommended that those at high risk for malnutrition see a registered dietician for preoperative nutritional optimization [42].
Nutritional support in malnourished patients should ideally begin preoperatively and continue postoperatively [44, 46]. Enteral nutrition is the preferred method for improving nutrition. Optimizing protein intake can reduce complication rates when started at least 5–7 days prior to major surgery [44, 46]. Use of parenteral nutrition is not recommended as there may be increased risk of POCs and infection. This should only be considered in those with an absolute contraindication to enteral feed­ing [44, 46].
Anemia
Anemia affects at least one-third of preoperative patients [4749]. Iron deciency anemia is the most common cause of anemia preoperatively [47, 49]. Preoperative anemia is associated with higher rates of postoperative mortality and morbidity including SSI, cardiac events, and LOSH [47, 49].
Mainstay of treatment is iron supplementation, and red blood cell transfusion should be avoided. Iron can be supplemented either orally or parenterally [47, 49]. Oral iron supplementation must be started 1 or 2 months in advance of surgery whereas parenteral iron should be given at least 2weeks preoperatively [49, 50]. The use of recombinant erythropoietin (EPO) to stimulate hematopoiesis in bone
500
https://t.me/med1917
marrow has come in and out of favor since it became available [45, 47, 48]. Meta­analysis of available studies suggest that EPO in combination with iron supplemen­tation does reduce the risk of transfusion perioperatively [47, 46]. Increased risk of thromboembolism with recombinant EPO products was a concern, but newer research suggests that those risks may be higher in prolonged use of EPO, while short term use immediately preoperatively may not have the same risk [47]. Given this, recombinant EPO can be considered along with iron supplementation in well­selected patients requiring correction of preoperative anemia and to support blood conservation management strategies [50].
R. Parrish and R. Findley
High-Risk, Non-cardiovascular Surgeries
High-risk surgeries are dened as procedures with possible signicant effect on hemodynamics and blood loss. These procedures include colorectal surgery with bowel resection; kidney transplant; major joint replacement (shoulder, knee, and hip); open radical prostatectomy or cystectomy; and major oncologic general, gyne­cologic, or head and neck surgery.
Common Postoperative Complications
Nausea andVomiting
Postoperative nausea and vomiting (PONV) are common complications of surgery and optimal management is sometimes complex [51]. Risk factors include female gender, a history of PONV or motion sickness, nonsmokers, and young age. The choice of anesthetic during surgery can impact these rates. Avoidance of opioids has been shown to reduce PONV and options include opioid-free total intravenous anes­thesia (TIVA), regional anesthesia, multimodal analgesia, beta-blockers, and admin­istration of alpha-agonists [51]. Nitrous oxide is a likely risk factor for PONV, but it appears to be related to exposure time as use less than an hour has a signicantly lower risk of PONV compared to longer exposures [51].
Preoperative prophylactic acetaminophen signicantly decreases opioid use and reduce rates of PONV.Intravenous use is best studied, but oral prophylaxis reduces opioid use and is less expensive [51]. Alpha-2 adrenergic receptor agonist dexmeto­midine administration prior to skin incision also reduces opioid use and PONV [51]. Use of neuraxial anesthesia, such as epidural anesthesia and transversus abdominus plane (TAP) blocks are other interesting alternatives [51].
Pharmacologic prophylaxis is recommended and newer guidelines suggest mul­timodal prophylaxis in those with one or more risk factors. Serotonin 5-HT3 recep­tor antagonists can be combined with dexamethasone, aprepitant, haloperidol, or betahistine. Non-5HT3 receptor antagonist containing combinations are also described [51].
29 Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery…
https://t.me/med1917
501
In those exhibiting PONV despite prophylaxis, using a pharmacologic agent from a different class is recommended as repeated dose of the former options within 6h has not been shown to provide additional benet [51]. In those who did not receive prophylaxis, 5-HT3 receptor antagonists are the rst-line therapy for treat­ing PONV.Nonpharmacologic therapies such as aromatherapy with isopropyl alco­hol or peppermint oil, ginger, and PC6 acupressure may all reduce PONV [51, 52].
Postoperative Ileus (Delayed Gastric Emptying)
Early feeding and early mobilization signicantly reduce the rate of postoperative ileus and are core components of ERAS® pathways [53, 54]. Epidural analgesia is also associated with a reduction in ileus compared to systemic analgesia, but may not ben­et LOSH [53]. Selective use of nasogastric tube drainage is recommended along with early removal [54]. A variety of pharmacologic and nonpharmacologic approaches has been trialed in the prevention of ileus, without consistent outcomes [55, 56].
The peripherally acting mu-opioid receptor antagonist, alvimopan, signicantly reduces the time to bowel recovery. Side-effects include hypokalemia and insomnia [57]. Methylnaltrexone and ghrelin receptor agonists do not reliably reduce the risk of ileus [57]. Data on serotonin receptor agonists as prophylaxis are more limited but mosapride may reduce the time to bowel recovery, whereas metoclopramide does not appear to reliably reduce ileus [57].
Glycemic andElectrolyte Imbalances
Perioperative glycemic control is recommended by most major societies as a strategy to reduce infections complications, lower mortality, and shorten LOSH [58]. This applies to both diabetic and non-diabetic patients. Attention should be paid to which agents are most likely to cause hypoglycemia in patients who are nil per os (NPO), as this is a potentially serious side-effect of anti-diabetic drugs. These higher risk agents, such as short-acting insulin, SGLT-2 inhibitors, meglitinides, and sulfonyl­ureas, should be held until patients are eating well [58]. Other agents can be contin­ued throughout the perioperative period with attention paid to a dose reduction for long-acting insulins [58]. In North America, it is common practice to withhold met­formin perioperatively; however, this agent does not cause hypoglycemia and the risk of lactic acidosis is extremely low. Given this, it should only be held if the patient’s eGFR is less than 30mL/min/1.73m levels above 180mg/dL (10mmol/L), intervention with basal bolus insulin therapy reduces POCs in comparison with traditional sliding-scale insulin regimens [58, 59].
Major electrolyte disturbances can occur in the postoperative period. Patients at higher risk include those with AKI, malnourished patients experiencing refeeding syndrome, patients with a malignancy, and those in the intensive care unit.
2
[58]. In patients with blood glucose
502
https://t.me/med1917
Disturbances in sodium levels are typically related to imbalances in total body water with correction being achieved after assessment for total body water excess or de­cit. Treatment of hyperkalemia requires removal of additional potassium supple­mentation in uids and binding or shifting potassium to facilitate removal. If there are no ECG changes and the patient has a functional bowel, then an oral agent such as sodium polystyrene (Kayexalate) can be used. If more urgent shifting is required, this can be achieved with insulin with accompanying glucose. If ECG changes are present, a parenteral dose of calcium is required for myocardial stabilization.
In the event of hypokalemia, this is replaced orally if the patient is asymptomatic and tolerating enteral nutrition, with the parenteral route used for symptomatic patients, those who cannot tolerate oral supplementation, or those with critically low values. Muild hypophosphatemia and hypomagnesemia are replaced with oral supplementation. Parenteral supplementation is indicated if the refeeding syndrome is suspected, or in those not tolerating enteral nutrition. Magnesium should be infused over a prolonged period, ideally 24h at up to 1g/h, to maximize absorption and minimize renal excretion [60].
R. Parrish and R. Findley
Acute Kidney Injury
Acute kidney injury (AKI) occurs with an increase in serum creatinine by 50% or greater within 7days, of greater than or equal to 0.3mg/dL (26.5mmol/L) within 48h, or oliguria in face of adequate uid intake [61]. Postoperative AKI is associ­ated with increased mortality and LOSH, as well as subsequent chronic kidney dis­ease [61]. The mechanism leading to kidney injury is often multifactorial and can include perfusion related injuries, nephrotoxic medications, urologic obstruction, and vasoconstriction [61]. Nephrotoxic medications may play a role in up to 30% of AKI [61].
NSAIDs may contribute to postoperative AKI, and routine prescription of 0.9% saline is associated with more postoperative AKI compared to balanced crystalloids in those at high risk [62]. Hypotension and prolonged hyperglycemia are both rec­ognized mechanisms [62]. If AKI is recognized, it is key to remove nephrotoxic medications and treat the underlying causes. Initial expansion of the intravascular volume is recommended with balanced crystalloids as opposed to colloids such as albumin. Diuretics can be initially tested provided hydration is maintained (euvolemia), and may be required if there is evidence of volume overload [62].
Urinary Retention
The incidence of postoperative urinary retention varies from 5% to 70% [63]. Risk factors include age over 50, male gender, major abdominal or pelvic surgery, neuro­logic complications (such as diabetic neuropathy, stroke, multiple sclerosis),
29 Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery…
https://t.me/med1917
prolonged surgery duration, medications, and receiving excess perioperative intra­venous uids [63]. Urinary retention has been precipitated by medications such as anticholinergics, opioids, anesthetics, alpha-adrenergic agonists, calcium channel blockers, detrusor relaxants, and benzodiazepines. Their prescription should be carefully analyzed in those with prostate hypertrophy or previous history of urinary retention [63, 64].
Standard of care management of urinary retention is bladder catheterization, whether this be intermittent or indwelling [63]. Prophylactic alpha-adrenergic blockers such as tamsulosin may attenuate urinary retention in both men and women; however, results are inconsistent [63, 65, 66].
503
Venous Thromboembolism (VTE)
VTE includes deep vein thrombosis and pulmonary embolism. These are common complications, occurring at rates of 15–38% and just under 1%, respectively, in those undergoing major general or gynecology surgery who do not receive prophy­laxis [67, 68]. Appropriate thromboprophylaxis can reduce the rate of VTE by 30–65% with low risk of complications [67]. Studies indicate that despite recom­mendations 40–60% of patients don’t receive appropriate prophylaxis [67].
Conventional guidelines with injectable drugs recommend thromboprophylaxis for all major general, gynecologic, and open urology operations with either low molecular weight heparin/ LMWH, low-dose unfractionated heparin (UFH), or sub­cutaneous fondaparinux [68]. In gynecologic oncology surgery VTE is decreased by just over 40% with either LMWH or low-dose UFH [67]. Giving aspirin alone is not deemed sufcient in any patient group [68]. Direct oral anticoagulants/DOAC for extended prophylaxis appear to provide a safe alternative to injectable medica­tions and may be more acceptable to patients [69]. The recommended length of postoperative prophylaxis varies widely among surgical groups, procedure type, and patient factors such as malignancy.
Blood Pressure Management
While blood pressure targets for ambulatory patients are clearly dened and well­researched, optimum blood pressure targets in the perioperative setting are less clear [70]. Intraoperative hypotension in non-cardiac surgery is associated with increased morbidity including cardiac and renal dysfunction, delirium, and postoperative mortality [70]. Intraoperative hypertension is not reliably associated with POCs [70]. Based on the available evidence for those undergoing non-cardiac surgery, identifying the patient’s baseline blood pressure, and maintaining intraoperative blood pressure within a range of up to 10% variance is suggested [70].
504
https://t.me/med1917
R. Parrish and R. Findley
Postoperative Hypotension/Hypertension
A systolic blood pressure of less than 90mmHg has been found to increase the risk of myocardial injury, stroke, and mortality [71]. This threshold may be higher in someone with preoperative hypertension and avoiding a drop in blood pressure by more than 30% of the patient’s baseline is suggested [71]. While many patients have a natural drop in their blood pressure by 10–20% while sleeping, some do not. Therefore, it is important to not ignore prolonged periods of hypotension unless the patient has been demonstrated to have lower blood pressures out of hospital [71].
Postoperative hypertension (systolic pressure greater than 180mmHg) is associ­ated with increased risk of heart attack, arrhythmia, pulmonary complications, stroke, and bleeding [71]. Curiously there is no demonstrated benet from lowering blood pressure substantially below 180mmHg postoperatively [71].
Cardiologic Medications
Continuing already prescribed beta-blockers postoperatively decreases short and long-term mortality. Conversely, holding a beta-blocker has been shown to increase mortality in those undergoing vascular surgery. A beta-blocker should be held post­operatively if a patient develops a third-degree heart block and the dose titrated or held in the setting of hypotension or severe bradycardia [71]. Angiotensin-converting enzyme inhibitors/ACEI and angiotensin receptor blockers/ARB should be restarted within 48h of surgery unless the patient has an elevation in creatinine levels or low blood pressure. Failure to restart these agents is associated with an increase in 30-day mortality, especially in those under age 60 [71]. Calcium channel blockers/ CCBs may reduce cardiac ischemia and arrhythmia in the perioperative period but guidance on reintroduction of these agents is limited by lack of evidence [71]. Similarly, evidence is limited on management of diuretics [71].
Atrial Fibrillation
Atrial brillation (AFib) occurs in up to 10% of patients undergoing non-cardiac surgery and the vast majority will revert to sinus rhythm prior to discharge [72]. Despite this, perioperative AFib is associated with an increased risk of early and late stroke (62% higher odds of early, 37% higher odds of late) and mortality (37–44% higher odds), particularly in those undergoing non-cardiac surgery [72]. In the POISE trial evaluating prophylactic metoprolol in the perioperative period, there were fewer new AFib events however signicantly higher rates of mortality and stroke [71, 72]. Therefore this practice is not encouraged. In contrast meta-analyses with cardiac surgery cohorts identied risk reduction with such drugs as amioda­rone, landiolol, and colchicine.
29 Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery…
https://t.me/med1917
Patients experiencing AFib in the perioperative period should be managed similar to those in the ambulatory setting. An assessment for predisposing factors preceding the AFib event is key, along with an evaluation on the need for ongoing anticoagula­tion [73]. According to Canadian guidelines, beta-blockers or nondihydropyridine calcium channel blockers (verapamil, diltiazem) should be considered as rst-line therapy for rate control in those with normal cardiac ejection fraction. Cardioversion should be considered for any patients deemed to be vitally unstable [73].
505
Shock andHemorrhage
In patients with postoperative shock, 30-day mortality rate is as high as 26%, and independent factors associated with short-term prognosis are the severity of clinical status at ICU admission, worsening organ dysfunction during the rst 3 days of ICU admission, and intraoperative coagulation disturbances [74]. The rst 3 days of ICU admission are important for overall survival [74]. Long-term mortality (>6months) is also associated with worsening early organ dysfunction, especially hepatic dys­function, and intraoperative coagulation disturbances, and the impact of comorbidi­ties [74]. The evolving concept of perioperative goal-directed uid (hemodynamic) therapy (GDFT) currently includes the use of uids and/or vasopressors to reach and maintain hemodynamic endpoints (systolic pressure>90mmHg, mean arterial pres­sure 60–65mmHg) and minimize postoperative circulatory complications [75, 76].
Perioperative GDFT to optimize uid status and hemodynamics, with the appro­priate use of uids as well as the use of earlier/preemptive inotropes and vasopressors has been adopted in some centers, however not in others [75]. Vasopressor selection (dopamine, norepinephrine, epinephrine, phenylephrine, vasopressin) should be based on rectifying underlying physiologic decits. Practically speaking, which agent is chosen initially does not seem as important as reaching and maintaining hemody­namic goals. A supraphysiologic goal for cardiac output has not been benecial and may cause morbidity [75]. A second medication with a different mechanism of action should be added when maximum doses of the initial agent are inadequate [75].
Myocardial Infarction inNon-cardiac Surgeries
Cardiogenic shock (CS) is a feared complication of acute myocardial infarction (AMI), and the mortality rate of patients with CS as a result of AMI is around 40–50%, within any setting [76]. Progression from AMI to CS can develop within hours after severe AMI, as a result of left ventricular systolic and diastolic dysfunc­tion (most common), acute mitral regurgitation, ventricular septal rupture, isolated right ventricular failure, tamponade or cardiac rupture [76]. While guidance for optimal pharmacologic therapy in patients with CS after AMI is scarce, guidelines recommend avoiding renin-angiotensin-aldosterone system inhibitors and beta­blockers until shock resolves [76].
506
https://t.me/med1917
R. Parrish and R. Findley
Surgical Site Infection
After implementing an ERAS® protocol for colorectal surgeries, a 2.5-fold decrease in SSI rate has been announced even if compliance with other individual bundle items is below 50%. However, compliance with preoperative antibiotic administra­tion alone is associated with improved outcomes [77]. Alternative non- cephalosporin regimens, especially ertapenem, may be as effective as cephalosporin-based regi­mens for preventing 30-day SSI; however, recent evidence suggests that alternative regimens may lead to worse outcomes [78].
Evidence of at least moderate certainty indicates reduced SSI risk when IV anti­biotics are administered prior to cesarean incision, breast cancer surgery, and hernia repair. Iodine-impregnated adhesive drapes are not recommended, and there is prob­ably no difference in SSI risk when antibiotics are stopped the day of surgery com­pared to longer duration during colorectal surgery [79]. Optimization of stroke volume and cardiac output is defended by some, so that circulation to the surgical wound area is not compromised [80].
GDFT seems to reduce SSI in cardiac, gastrointestinal, and other non-cardiac surgeries, but not in vascular or orthopedic procedures [80]. Respiratory and urinary system infectious complications were also less frequent, however not sepsis or sep­tic shock [80]. Visceral surgery patients with reported penicillin allergy can be treated with a cephalosporin or ertapenem; however, true cephalosporin allergy requires alternative therapy with gentamicin and clindamycin or metronidazole [81]. Oral antibiotic gut sterilization has very rare indications nowadays, and even for laparoscopic bowel and rectal procedures it is sometimes questioned [55].
Pain Management
As many as 55% of patients have POCs that are related to higher pain levels [82]. Diabetes is an independent predictor of postoperative pain, and about 30% of dia­betics experience neuropathic pain [80]. Younger patients experience more pain intensity and this could be explained by reduced renal clearance of opioids in the elderly [82]. See Table29.3 for a suggested multimodal protocol which reduced the frequency and severity of postoperative pain by 50% in colorectal surgery [82]. Minimally invasive surgery (MIS) is deemed less painful than open surgery, how­ever outcomes are inconsistent, for instance when anterior rectal resection and abdominal perineal rectal excision modalities are compared [82].
IV lidocaine, although benecial in select cases, is currently not considered the standard of care for acute pain management due to the primarily observational data supporting its safe and effective use, with scarce prospective protocols [83]. Compared with sufentanil, hydromorphone may signicantly reduce postoperative pain, with no signicant difference in sedation and patient-controlled analgesia requests. In addition, the incidence of PONV and somnolence with hydromorphone could be lower [84].
29 Optimal Pharmacotherapy Strategies for Enhanced Postoperative Recovery…
https://t.me/med1917
507
Table 29.3
Pharmacotherapy recommendations for preventing common postoperative
complications (expanded from Parrish etal. [1])
Postoperative complication Recommendations (consider alternatives for shortages)
Nausea and vomiting Preoperative complex carbohydrate loading
Aprepitant 1–3h prior for 2 risk factors Female patients: Other non-hormonal contraception for at least 28days postoperatively Scopolamine patch (skin behind ear for 72h); reduce patch for children and elderly; Intraoperative dexamethasone 8–10mg IV (half-life 36–54h); half dose in diabetes; Postoperative (48h): 5HT polonosetron); dopamine (D
I (ondansetron, granisetron,
3
) antagonists (metoclopramide,
2
droperidol, prochlorperazine); Histamine-1 antagonists (diphenhydramine, dimenhydrinate, trimethobenzamide);
Ileus Alvimopan 12mg oral if taking opioids; <15 doses due to increased
risk of MI; stop upon passing atus Naloxegol 12.5–25mg oral Naldemedine 0.2mg oral
Glycemic and electrolyte imbalances
Previous short-acting insulin, SGLT-2 inhibitors, meglitinides, and sulfonylureas should be held until eating well Other oral agents/long-acting insulin continued at a lower dose Basal bolus insulin therapy (BBIT) for hyperglycemia
Acute kidney injury/AKI GDFT: Enough uids to minimize risk of renal injury
Hold NSAIDs and other nephrotoxic agents Initial bolus balanced crystalloids if AKI suspected
Urinary retention GDFT review (dehydration?); minimization of opioids
Catheterization if in doubt
Venous thromboembolism LMWHs or DOACs (>12h after neuraxial anesthesia)
Avoid rivaroxaban/dabigatran for elderly (bleeding risk) Continue 28days in cancer/other high-risk cases
High blood pressure ACEI/ARBs re-initiated within 48h unless hypotensive
Hold antihypertensives: Systolic<90mmHg or 30% below patient’s baseline
Atrial brillation Beta-blockers: Continue if on pre-operatively;
Beta-blockers/calcium channel blocker: Initiated if stable Unstable: Consider cardioversion
Delirium Avoid benzodiazepines/gabapentinoids
Avoid uid fasting; clear liquids until 1–2h preoperatively Pharmacotherapy elimination (non-essentials) Multimodal opioid-sparing analgesia: Acetaminophen, COX-2 NSAIDs (celecoxib, meloxicam); review opioids (chronic pain);
Shock and hemorrhage Consider GDFT for raising mean arterial pressure (MAP)
Norepinephrine in non-cardiogenic shock if uid bolus inadequate Add arginine vasopressin, milrinone if MAP still low
Non-CS acute myocardial infarction
Consider LMWH for anticoagulation Avoid renin-angiotensin-aldosterone inhibitors (ACEI, ARB, spironolactone) and beta-blockers until shock resolves
(continued)